This is a preview of subscription content, access via your institution.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Flanagan EP, McKeon A, Lennon VA et al (2011) Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76(24):2089–2095
Flanagan EP, Keegan BM (2013) Paraneoplastic myelopathy. NeurolClin 31(1):307–318
Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B (2020) Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate. Mult Scler Relat Disord 46:102468
Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J NeurolNeurosurg Psychiatry 75:1135–1140
Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65(5):629–632 (published correction appears in Arch Neurol. 2008 Oct;65(10):1394)
Keegan BM, Pittock SJ, Lennon VA (2008) Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol 63(4):531–534
Conflict of interest
The authors declare that they have no competing interest.
Ethical approval from the institutional review board was not required for this study.
Formal consent was taken from the patient.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cherian, A., Shetty, S.C., Divya, K.P. et al. MOG antibody-positive paraneoplastic myelopathy in breast carcinoma: the new culprit. Acta Neurol Belg (2021). https://doi.org/10.1007/s13760-021-01602-8